HLX43 1 is named as a drug or biological intervention in 7 clinical trials in our China and USA trial registers, 5 of which are recruiting. The lead sponsor is Shanghai Henlius Biotech. Registered phases: Phase 2 and Phase 1/2. Conditions studied include Non Small Cell Lung Cancer; Gastric or Gastroesophageal Junction Adenocarcinoma; Colorectal Cancer (CRC).
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Non Small Cell Lung Cancer | 2 |
| Gastric or Gastroesophageal Junction Adenocarcinoma | 1 |
| Colorectal Cancer (CRC) | 1 |
| Colon Cancer Adenocarcinoma | 1 |
| Nasopharyngeal Carcinoma (NPC) | 1 |
| Small Cell Lung Cancer | 1 |
| Breast Cancer (Triple Negative Breast Cancer (TNBC)) | 1 |
| Lead sponsor | Trials |
|---|---|
| Shanghai Henlius Biotech | 7 |
| Register | HLX43 1 trials |
|---|---|
| Clinical trials in China | 7 |
| Clinical trials in USA | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how HLX43 1 works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists HLX43 1 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.